Search research articles
Contact Us
Filters
Showing results (71-80 of 84) with videos related to
Page
of 9
Sort By:
Transplantation
|
February 1, 1994
The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts
S K Pruitt, A D Kirk, R R Bollinger, et al.
Annals of Surgical Oncology
|
March 5, 2013
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion
Gina Shetty, Georgia M Beasley, Sara Sparks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2004
The role of hyperthermia in regional alkylating agent chemotherapy
Omar I Abdel-Wahab, Elizabeth Grubbs, Benjamin L Viglianti, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity
Sae Hee Ko, Tomio Ueno, Yasunori Yoshimoto, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy
Christina K Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, et al.
The Journal of Clinical Investigation
|
August 13, 2013
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
Jens Dannull, N Rebecca Haley, Gary Archer, et al.
Journal of the American College of Surgeons
|
May 30, 2009
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US
Georgia M Beasley, Abigail Caudle, Rebecca P Petersen, et al.
The Journal of Pathology. Clinical Research
|
April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119
Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 84) with videos related to
Sort By:
Page
of 9
Transplantation
|
February 1, 1994
The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts
S K Pruitt, A D Kirk, R R Bollinger, et al.
Annals of Surgical Oncology
|
March 5, 2013
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion
Gina Shetty, Georgia M Beasley, Sara Sparks, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 10, 2004
The role of hyperthermia in regional alkylating agent chemotherapy
Omar I Abdel-Wahab, Elizabeth Grubbs, Benjamin L Viglianti, et al.
Molecular Cancer Therapeutics
|
March 21, 2006
Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine
Tomio Ueno, Sae Hee Ko, Elizabeth Grubbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 7, 2006
Optimizing a novel regional chemotherapeutic agent against melanoma: hyperthermia-induced enhancement of temozolomide cytotoxicity
Sae Hee Ko, Tomio Ueno, Yasunori Yoshimoto, et al.
Molecular Cancer Therapeutics
|
June 24, 2010
Sorafenib, a multikinase inhibitor, enhances the response of melanoma to regional chemotherapy
Christina K Augustine, Hiroaki Toshimitsu, Sin-Ho Jung, et al.
The Journal of Clinical Investigation
|
August 13, 2013
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome
Jens Dannull, N Rebecca Haley, Gary Archer, et al.
Journal of the American College of Surgeons
|
May 30, 2009
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US
Georgia M Beasley, Abigail Caudle, Rebecca P Petersen, et al.
The Journal of Pathology. Clinical Research
|
April 17, 2024
Contribution of tumour and immune cells to PD-L1 expression as a predictive biomarker in metastatic triple-negative breast cancer: exploratory analysis from KEYNOTE-119
Javier Cortes, Eric P Winer, Oleg Lipatov, et al.
Page
of 9